A Study to Investigate the Effect of Rifampicin on the PK of Multiple Doses of Balovaptin In Healthy Volunteers
Clinical trial NCT03586726 · COMPLETED
Trial details
- NCT number
- NCT03586726
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-24
- Primary completion
- 2018-11-02
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.